Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 12Gastrointestinal 6Genitourinary 4Thoracic 3Tumor-Agnostic 2Plasma cell 1Other neoplasm 1Other hematologic neoplasm 1Other 1Lymphoid 1Gynecologic 1

Conditions

Polycystic Ovary Syndrome 1Obesity 1Lipid Metabolism Disorders 1Diabetes Mellitus 1Cardiovascular Diseases 1

Interventions

Exercise 28Metformin 24Surveys and Questionnaires 19Radiotherapy 14Methods 14Early Intervention, Educational 13Counseling 13Educational Status 12naloxegol 10Standard of Care 10Tirzepatide 9Nutrition Assessment 9Diet Therapy 9Cisplatin 9Resistance Training 8Psychiatric Rehabilitation 8Diet 8Therapeutics 7Interviews as Topic 7alvimopan 6Liraglutide 6Fibroblast Growth Factor 7 6Caloric Restriction 6semaglutide 5Radiation 5Low-Level Light Therapy 5Injections 5Exenatide 5Diet, Mediterranean 5Dexamethasone 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Fish Oils × Other × Clear all
NCT04116203 2025-02-28

PCOS

University of Alberta

Phase 1 Completed
52 enrolled
Other

Cardiovascular Diseases, Diabetes Mellitus, Obesity, Polycystic Ovary Syndrome, Lipid Metabolism Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡